startup.bid
FR
EnglishEspañolPortuguêsFrançaisDeutschItalianoNederlandsSvenskaDanskNorskPolskiSlovenščinaTürkçeРусскийBahasa IndonesiaBahasa MelayuFilipinoTiếng ViệtKiswahiliहिन्दीاردوالعربيةעברית日本語한국어中文繁體中文

YourChoice Therapeutics

YourChoice therapeutics is revolutionizing the contraceptive market…

À propos

Description de l’entreprise en anglais

YourChoice Therapeutics is revolutionizing the global contraceptive market. Our vision is to develop non-hormonal contraceptives to provide both women and men with birth control options that lack the associated risks of hormone-based options but are equally effective. Traditionally, it has been the women’s financial and health burden to have a contraceptive in place. Our first goal is therefore to bring a novel non-hormonal, on-demand and low cost female contraceptive to the market that will substantially improve their quality of life and well-being. Our second goal is to develop the first ever non-surgical and highly effective non-hormonal contraceptive for men. Currently, male contraception is limited to two main options – vasectomy or condoms. Having such options available to both women and men will globally allow for much better family planning, reduce the number of unwanted pregnancies including abortions and therefore reduce costs and ensure contraceptive health and well-being.

Thèmes

Health TechBiotechHealthcareTherapeutics
Localisation
San Francisco, CA, États-Unis
Équipe
3 employés
Promotion YC
Winter 2019
Statut
Active
Stade
Phase d’amorçage

Startups similaires et concurrents

Questions et réponses

Où se trouve YourChoice Therapeutics ?

San Francisco, CA, États-Unis

Combien de personnes travaillent chez YourChoice Therapeutics ?

3 employés, d’après le profil de l’entreprise.

L’entreprise YourChoice Therapeutics a-t-elle levé des fonds ?

Nos données ne contiennent aucune levée de fonds pour YourChoice Therapeutics.

Quelles sont les alternatives à YourChoice Therapeutics ?

Startups similaires : Probably Genetic, Pirouette Pharma et Immunity Project.